Growth Metrics

Conmed (CNMD) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -6.51%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 7.96%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -2.19%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 64.73%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 30.89%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 60.12%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 29.56%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Conmed 1.06 Bn 1.02 Bn 183.45 Mn 96.63%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 96.63%
Dec 31, 2025 -14.29%
Sep 30, 2025 -60.43%
Jun 30, 2025 28.61%
Mar 31, 2025 -26.13%
Dec 31, 2024 11.36%
Sep 30, 2024 48.53%
Jun 30, 2024 31.14%
Mar 31, 2024 25.97%
Dec 31, 2023 11.06%
Sep 30, 2023 32.23%
Jun 30, 2023 35.74%
Mar 31, 2023 -32.55%
Dec 31, 2022 21.19%
Sep 30, 2022 87.78%
Jun 30, 2022 -215.99%
Mar 31, 2022 144.78%
Dec 31, 2021 16.02%
Sep 30, 2021 36.91%
Jun 30, 2021 15.09%
Mar 31, 2021 -2.56%
Dec 31, 2020 -19.74%
Sep 30, 2020 -1.63%
Jun 30, 2020 -86.27%
Mar 31, 2020 48.94%
Dec 31, 2019 30.58%
Sep 30, 2019 -1.70%
Jun 30, 2019 25.46%
Mar 31, 2019 34.82%
Dec 31, 2018 25.86%
Sep 30, 2018 -13.09%
Jun 30, 2018 5.33%
Mar 31, 2018 19.08%
Dec 31, 2017 60.29%
Sep 30, 2017 53.96%
Jun 30, 2017 -15.72%
Mar 31, 2017 -36.21%
Dec 31, 2016 -13.11%
Sep 30, 2016 8.86%
Jun 30, 2016 -32.87%
Mar 31, 2016 -30.37%
Dec 31, 2015 -10.35%
Sep 30, 2015 -1.62%
Jun 30, 2015 -10.18%
Mar 31, 2015 -14.13%
Dec 31, 2014 34.83%
Sep 30, 2014 -37.84%
Jun 30, 2014 5.72%
Mar 31, 2014 -1.39%
Dec 31, 2013 13.67%
Sep 30, 2013 -13.41%
Jun 30, 2013 9.27%